The NanoGAS™ series has been approved as an officially recommended product by the Japanese Society of Preemptive Clinical Medicine.

Synbiosis’ proprietary NanoGAS™ series, which supports our group’s transplantation bacteriological solutions, has been approved as an officially recommended product by the Japanese Society of Preemptive Clinical Medicine.

The transplanted bacteria solution used in our research group is Ultra Fine Bubble (NanoGAS™) water, which contains invisible microscopic bubbles.
By utilizing the properties of Ultra Fine Bubble, we expect to effectively transplant intestinal bacteria of other people’s origin, which were originally considered to be blocked by autoimmune functions such as IgA (immunoglobulin A) and could not successfully take up residence.

Click here to learn more about the three properties and functions of the patent-pending Ultra Fine Bubble.

We are pleased to announce that the NanoGAS™ series from Symbiosis, Inc. is now available for purchase as samples in small lots for a fee.
We have received requests for samples from a wide variety of companies and have responded to each request individually, but now we are pleased to announce that corporate customers can try our products.

Please see below for more details. Thank you for your continued support of the NanoGAS™ series.